No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response


  • Start complement inhibition (eculizumab/ravulizumab)

Map: TMA (792)
Node: 16365
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Για να προστατεύσουμε τα ρούχα μας από κάτω. Το λευκό ταιριάζει με κάθε χρωματικό τόνο του δέρματος.
  • Option 1
  • Option 3
  • Pentru a genera segmente individuale de ADN, asigurând o scindare eficientă
  • No, although the patient and caregiver consent, the patient has no known mutation and complete clinical response

Reminder

FINISH

Time is up